1. Intraarterial drug delivery for glioblastoma mutiforme

   • Shailendra Joshi
   • Jason A. Ellis
   • Jeffrey N. Bruce

   Topic Review 25 June 2015 Pages: 333 - 343

   

2. Randomized controlled trials and neuro-oncology: should alternative designs be considered?

   • Alireza Mansouri
   • Samuel Shin
   • Douglas Kondziolka

   Topic Review 22 August 2015 Pages: 345 - 356

   

3. Nrdp1-mediated ErbB3 degradation inhibits glioma cell migration and invasion by reducing cytoplasmic localization of p27^Kip1

   • Hengliang Shi
   • Hui Gong
   • Rutong Yu

   Laboratory Investigation 19 June 2015 Pages: 357 - 364

   

4. VB-111: a novel anti-vascular therapeutic for glioblastoma multiforme

   • Aleksandra Gruslova
   • David A. Cavazos
   • Andrew J. Brenner

   Laboratory Investigation 25 June 2015 Pages: 365 - 372

   

5. Involvement of CD9 and PDGFR in migration is evolutionarily conserved from Drosophila glia to human glioma

   • Astrid Jeibmann
   • Kathrin Halama
   • Werner Paulus

   Laboratory Investigation 30 July 2015 Pages: 373 - 383

   

6. Differential gene methylation in paired glioblastomas suggests a role of immune response pathways in tumor progression

   • Agustí Alentorn
   • Alberto Durán-Peña
   • Charles Vecht

   Laboratory Investigation 30 July 2015 Pages: 385 - 392

   

7. A multi-resolution textural approach to diagnostic neuropathology reporting

   • Mohammad Faizal Ahmad Fauzi
   • Hamza Numan Gokozan
   • Metin N. Gurcan

   Laboratory Investigation 09 August 2015 Pages: 393 - 402

   

8. Colchicine derivative as a potential anti-glioma compound

   • Kuan-Min Fang
   • Jun-Jen Liu
   • Shun-Fen Tzeng

   Laboratory Investigation 04 August 2015 Pages: 403 - 412

   

9. Phase II trial of pre-irradiation and concurrent temozolomide in patients with newly diagnosed anaplastic oligodendrogliomas and mixed anaplastic oligoastrocytomas: long term results of RTOG BR0131

   • Michael A. Vogelbaum
   • Chen Hu
   • Minesh P. Mehta

   Clinical Study 19 June 2015 Pages: 413 - 420

   

10. Leptomeningeal disease following stereotactic radiosurgery for brain metastases from breast cancer

    • Daniel M. Trifiletti
    • Kara D. Romano
    • Jason Sheehan

    Clinical Study 21 June 2015 Pages: 421 - 427

    

11. Salvage whole brain radiotherapy or stereotactic radiosurgery after initial stereotactic radiosurgery for 1–4 brain metastases

    • Yufei Liu
    • Brian M. Alexander
    • Nils D. Arvold

    Clinical Study 25 June 2015 Pages: 429 - 437

    

12. Stereotactic radiosurgery in the treatment of brain metastases from gastrointestinal primaries

    • Daniel M. Trifiletti
    • Nirav Patel
    • Jason P. Sheehan

    Clinical Study 18 July 2015 Pages: 439 - 446

    

13. Genomic predictors of patterns of progression in glioblastoma and possible influences on radiation field design

    • Jordan A. Holmes
    • Anna K. Paulsson
    • Michael D. Chan

    Clinical Study 18 July 2015 Pages: 447 - 453

    

14. Clinical presentation and long-term outcome of primary spinal peripheral primitive neuroectodermal tumors

    • Xianzeng Tong
    • Xiaofeng Deng
    • Yulun Xu

    Clinical Study 18 July 2015 Pages: 455 - 463

    

15. Voxel-based evidence of perfusion normalization in glioblastoma patients included in a phase I–II trial of radiotherapy/tipifarnib combination

    • Soléakhéna Ken
    • Alexandra Deviers
    • Anne Laprie

    Clinical Study 19 July 2015 Pages: 465 - 473

    

16. RETRACTED ARTICLE: Relationship between inflammatory cytokines and risk of depression, and effect of depression on the prognosis of high grade glioma patients

    • Jian-tong Jiao
    • Jun Sun
    • Jun-fei Shao

    Clinical Study 28 July 2015 Pages: 475 - 484

    

17. Phase II trial of sunitinib as adjuvant therapy after stereotactic radiosurgery in patients with 1–3 newly diagnosed brain metastases

    • Manmeet S. Ahluwalia
    • Samuel T. Chao
    • David M. Peereboom

    Clinical Study 06 August 2015 Pages: 485 - 491

    

18. IDH1 mutation is prognostic for diffuse astrocytoma but not low-grade oligodendrogliomas in patients not treated with early radiotherapy

    • Yasuo Iwadate
    • Tomoo Matsutani
    • Naokatsu Saeki

    Clinical Study 05 August 2015 Pages: 493 - 500

    

19. Wound healing complications in brain tumor patients on Bevacizumab

    • Harshad Ladha
    • Tushar Pawar
    • Terri S. Armstrong

    Clinical Study 23 August 2015 Pages: 501 - 506

    

20. Control of brain metastases from radioresistant tumors treated by stereotactic radiosurgery

    • Andrew Yaeh
    • Tavish Nanda
    • Tony J. C. Wang

    Clinical Study 02 August 2015 Pages: 507 - 514

    

21. Brachytherapy in the treatment of recurrent aggressive falcine meningiomas

    • Hussam Abou Al-Shaar
    • Kaith K. Almefty
    • Ossama Al-Mefty

    Clinical Study 08 August 2015 Pages: 515 - 522

    

22. Management of late extraneural recurrence of medulloblastoma without high-dose chemotherapy

    • Richard E. Phillips
    • Kevin J. Curran
    • Yasmin Khakoo

    Letter to the Editor 27 June 2015 Pages: 523 - 524

23. Genetic imprinting suggested by maternal DNA methylation in CNS hemangioblastoma with clinical phenotypes of VHL disease

    • Dexuan Ma
    • Ying Wang
    • Liangfu Zhou

    Letter to the Editor 21 June 2015 Pages: 525 - 527

    

24. Whither thiotepa (for patients in the USA)?

    • Christopher Dardis
    • Kelly Milton
    • Lynn Ashby

    Letter to the Editor Open access 26 July 2015 Pages: 529 - 530